QUOTED. 12 February 2020. Tomer Lark.
Israel start-up Serenno Medical is planning a US launch for the Sentinel continuous urine output monitor for automatic monitoring and detection of acute kidney injury in patients treated in an intensive care unit. See what Serenno's CEO, Tomer Lark, said about it here.
“There is a clear unmet medical need for the automated monitoring of urine output for ICU patients. Repeated attempts at creating a device that delivers quality data from urine output and can alert physicians to possible kidney damage have, so far, not met with commercial success." – Tomer Lark, CEO, Serenno Medical
- Find out more: Start-Up Spotlight: BioIntelliSense Launches New FDA-Cleared BioSticker For Remote Monitoring Of Patients' Vital Signs
Click here for a free trial of Medtech Insight